首页 | 本学科首页   官方微博 | 高级检索  
检索        


Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): Challenges of conducting a feasibility trial
Authors:Najibah A Galadanci MBBS  FMCPath  Shehu U Abdullahi MD  FWACPaed  Musa A Tabari MBBS  FMCR  FICS  Shehi Abubakar MBBS  Raymond Belonwu MBBS  FWACPaed  Auwal Salihu MBBS  FMCPsych  Kathleen Neville MD  MS  Fenella Kirkham MD  FRCP  FRCPCH  Baba Inusa MD  FRCPCH  DCP  Yu Shyr PhD  Sharon Phillips MSPH  Adetola A Kassim MBBS  FMCPath  Lori C Jordan MD  PhD  Muktar H Aliyu MBBS  MPH  DrPH  Brittany V Covert MPH  Michael R DeBaun MD  MPH
Institution:1. Department of Haematology and Blood Transfusion, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria;2. Department of Pediatrics, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria;3. Department of Radiology, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria;4. Department of Psychiatry, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria;5. Department of Pediatric Hematology/Oncology, University of Missouri‐Kansas City School of Medicine, Kansas City, Missouri;6. Department of Pediatrics, University College of London Institute of Child Health, London, UK;7. Department of Pediatrics, Evelina's Children's Hospital, Guy's and St. Thomas', London, UK;8. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee;9. Department of Hematology and Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee;10. Department of Pediatrics, Division of Pediatric, Neurology, Vanderbilt University Medical Center, Nashville, Tennessee;11. Vanderbilt Institute for Global Health, Nashville, Tennessee;12. Department of Pediatrics, Hematology and Oncology, Vanderbilt‐Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, Tennessee
Abstract:
Keywords:hydroxyurea  Nigeria  primary stroke prevention  sickle cell disease
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号